AQR Capital Management
PRAX icon

AQR Capital Management’s Praxis Precision Medicines PRAX Stock Holding History

AQR Capital Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.6M Sell
58,446
-210
-0.4% -$66.5K 0.01% 1196
2026
Q1 		$18.9M Buy
58,656
+29,828
+103% +$9.23M 0.01% 1059
2025
Q4 		$8.5M Buy
28,828
+6,924
+32% +$1.29M ﹤0.01% 1290
2025
Q3 		$1.16M Buy
21,904
+7,324
+50% +$355K ﹤0.01% 2339
2025
Q2 		$613K Buy
+14,580
New +$555K ﹤0.01% 2496
2025
Q1 		– Sell
-6,704
Closed -$516K – 3185
2024
Q4 		$516K Sell
6,704
-18,564
-73% -$1.34M ﹤0.01% 2239
2024
Q3 		$1.45M Buy
+25,268
New +$1.36M ﹤0.01% 1656
2023
Q2 		– Sell
-4,973
Closed -$60.3K – 2258
2023
Q1 		$60.3K Sell
4,973
-5,729
-54% -$242K ﹤0.01% 2135
2022
Q4 		$382K Sell
10,702
-6,081
-36% -$190K ﹤0.01% 1907
2022
Q3 		$571K Buy
16,783
+15,623
+1,347% +$778K ﹤0.01% 1728
2022
Q2 		$43K Buy
+1,160
New +$124K ﹤0.01% 2140

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

AQR Capital Management's PRAX Position: Q2 2026 in Review

AQR Capital Management reduced its Praxis Precision Medicines (PRAX) stake by 0.36% in Q2 2026, selling an estimated $66.5K and leaving 58,446 shares worth $19.6M. The position accounts for 0.01% of the portfolio, ranked #1196.

AQR Capital Management first reported a position in PRAX in Q2 2022 and has held it in 11 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • AQR Capital Management held 58,446 shares of Praxis Precision Medicines worth $19.6M as of Q2 2026.
  • AQR Capital Management sold 210 Praxis Precision Medicines shares in Q2 2026, an estimated $66.5K.
  • Praxis Precision Medicines made up 0.01% of AQR Capital Management's portfolio in Q2 2026, its #1196 holding.
  • AQR Capital Management first reported a position in Praxis Precision Medicines in Q2 2022 and has held it in 11 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.